Inhibition of AURKA destabilizes glioblastoma primary cilia and sensitizes cells to tumor treating fields (TTFields) in vitro and ex vivo

被引：0
|
作者：
Tian, Jia
Mallinger, Julianne
Shi, Ping
Ling, Dahao
Deleyrolle, Loic
Lin, Min
Khoshbouei, Habibeh
Sarkisian, Matthew
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-5961
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5961
引用
收藏
页数：2
相关论文
共 50 条
  • [31] PI3K Inhibition Sensitized Cancerous Cells to Tumor Treating Fields (TTFields)
    Klein-Goldberg, A.
    Voloshin, T.
    Zemer-Tov, E.
    Paz, R.
    Koren, L.
    Wainer-Katsir, K.
    Volodin, A.
    Koltun, B.
    Brant, B.
    Barsheshet, Y.
    Kan, T.
    Haber, A.
    Giladi, M.
    Weinberg, U.
    Palti, Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E276 - E277
  • [32] The combined treatment of 150 kHz tumor treating fields (TTFields) and cisplatin or pemetrexed inhibits mesothelioma cells in vitro and in vivo.
    Weinberg, Uri
    Munster, Mijal
    Gotlib, Karnit
    Schneiderman, Rosa S.
    Porat, Yaara
    Voloshin, Tali
    Davidi, Shiri
    Shteingauz, Anna
    Kaynan, Noa
    Zeevi, Einav
    Giladi, Moshe
    Kirson, Eilon David
    Kinzel, Adrian
    Palti, Yoram
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [33] Inhibition of PI3K sensitized cancer cells to Tumor Treating Fields (TTFields)
    Klein-Goldberg, Anat
    Voloshin, Tali
    Zemer-Tov, Efrat
    Paz, Rom
    Koren, Lilach
    Wainer-Katsir, Kerem
    Volodin, Alexandra
    Koltun, Bella
    Brant, Boris
    Barsheshet, Yiftah
    Kan, Tal
    Haber, Adi
    Giladi, Moshe
    Weinberg, Uri
    Palti, Yoram
    CANCER RESEARCH, 2022, 82 (12)
  • [34] PI3K INHIBITION FOR SENSITIZING CANCER CELLS TO TUMOR TREATING FIELDS (TTFIELDS)
    Klein-Goldberg, A.
    Voloshin, T.
    Zemer-Tov, E.
    Paz, R.
    Somri-Gannam, L.
    Volodin, A.
    Koren, L.
    Wainer-Katsir, K.
    Haber, A.
    Dor-On, E.
    Giladi, M.
    Weinberg, U.
    Palti, Y.
    NEURO-ONCOLOGY, 2023, 25
  • [35] Tumor-treating fields (TTFields) interfere with biological key properties of glioma cells in vitro
    Silginer, Manuela
    Weller, Michael
    Stupp, Roger
    Roth, Patrick
    CANCER RESEARCH, 2017, 77
  • [36] LONG-LASTING TUMOR TREATING FIELDS (TTFIELDS) STIMULATION OF GLIOBLASTOMA PRIMARY CULTURE DAMAGES PREFERENTIALLY FULLY DIFFERENTIATED CANCER CELLS
    Castiglione, Stefania
    Ranucci, Matteo
    Cannavale, Gaetano
    Cianci, Francesca
    Verduci, Ivan
    Mazzanti, Michele
    NEURO-ONCOLOGY, 2020, 22 : 198 - 198
  • [37] Evaluation of tumor treating fields (TTFields) effects at 200 kHz on a glioblastoma, an anaplastic ependymoma and an oligodendroglioma sample in a patient-derived ex vivo organoid model
    Nickl, Vera
    Schulz, Ellina
    Salvador, Ellaine
    Trautmann, Laureen
    Diener, Leopold
    Kessler, Almuth F.
    Monoranu, Camelia M.
    Ernestus, Ralf-Ingo
    Lohr, Mario
    Hagemann, Carsten
    CANCER RESEARCH, 2023, 83 (07)
  • [38] ASSESSMENT OF TUMOR TREATING FIELDS (TTFIELDS) COMBINED WITH TRICHOSTATIN A (TSA) IN PATIENT-DERIVED GLIOBLASTOMA (GBM) CELLS
    Ma, Manxiu
    Michelhaugh, Sharon
    Mittal, Sandeep
    NEURO-ONCOLOGY, 2021, 23 : 35 - 35
  • [39] The efficacy of the combined treatment of 150 KHz tumor treating fields (TTFields) and Sorafenib in hepatocellular carcinoma in vitro and in vivo
    Voloshin, Tali
    Davidi, Shiri
    Tempel-Brami, Catherine
    Munster, Mijal
    Gotlib, Karnit
    Zeevi, Einav
    Schneiderman, Rosa S.
    Giladi, Moshe
    Kinzel, Adrian
    Kirson, Eilon D.
    Weinbergand, Uri
    Palti, Yoram
    CANCER RESEARCH, 2019, 79 (13)
  • [40] Tumor treating fields (TTFields) increase cancer cell membrane permeability and improve sensitivity to doxorubicin in vitro and in vivo
    Koltun, Bella
    Voloshin, Tali
    Kan, Tal
    David, Cfir
    Koren, Lilach
    Porat, Yaara
    Volodin, Alexandra
    Kaynan, Noa
    Klein-Goldberg, Anat
    Paz, Rom
    Brant, Boris
    Barsheshet, Yiftah
    Zemer-Tov, Efrat
    Haber, Adi
    Giladi, Moshe
    Weinberg, Uri
    Palti, Yoram
    CANCER RESEARCH, 2024, 84 (06)
12345